Literature DB >> 23983985

Neonatal hypoglycaemia following maternal olanzapine therapy during pregnancy: a case report.

Melissa Rowe1, Bharath A Gowda, David Taylor, Simon Hannam, Louise M Howard.   

Abstract

Entities:  

Year:  2012        PMID： 23983985      PMCID： PMC3736951          DOI： 10.1177/2045125312460395

Source DB:  PubMed          Journal:  Ther Adv Psychopharmacol        ISSN： 2045-1253


× No keyword cloud information.
  15 in total

1.  The causes of neonatal hypoglycemia.

Authors:  C A Stanley; L Baker
Journal:  N Engl J Med       Date:  1999-04-15       Impact factor: 91.245

Review 2.  Obesity and insulin resistance.

Authors:  B B Kahn; J S Flier
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Birth weight and use of olanzapine in pregnancy: a prospective comparative study.

Authors:  Girish N Babu; Geetha Desai; Harish Tippeswamy; Prabha S Chandra
Journal:  J Clin Psychopharmacol       Date:  2010-06       Impact factor: 3.153

4.  Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.

Authors:  Kate McKenna; Gideon Koren; Maria Tetelbaum; Lynda Wilton; Saad Shakir; Orna Diav-Citrin; Andrea Levinson; Robert B Zipursky; Adrienne Einarson
Journal:  J Clin Psychiatry       Date:  2005-04       Impact factor: 4.384

5.  Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state.

Authors:  Montserrat Victoriano; Renaud de Beaurepaire; Nadia Naour; Michèle Guerre-Millo; Annie Quignard-Boulangé; Jean-François Huneau; Véronique Mathé; Daniel Tomé; Dominique Hermier
Journal:  Brain Res       Date:  2010-06-04       Impact factor: 3.252

6.  A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder.

Authors:  Roger S McIntyre; Susan L McElroy; James M Eudicone; Robert A Forbes; Berit X Carlson; Ross A Baker
Journal:  Prim Care Companion CNS Disord       Date:  2011

7.  Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects.

Authors:  Robert Bodén; Maria Lundgren; Lena Brandt; Johan Reutfors; Helle Kieler
Journal:  Arch Gen Psychiatry       Date:  2012-07

8.  Birth weight of infants after maternal exposure to typical and atypical antipsychotics: prospective comparison study.

Authors:  James J Newham; Simon H Thomas; Karine MacRitchie; Patricia R McElhatton; R Hamish McAllister-Williams
Journal:  Br J Psychiatry       Date:  2008-05       Impact factor: 9.319

9.  Olanzapine induces insulin resistance: results from a prospective study.

Authors:  Christoph F Ebenbichler; Markus Laimer; Ursula Eder; Barbara Mangweth; Elisabeth Weiss; Alex Hofer; Martina Hummer; Georg Kemmler; Monika Lechleitner; Josef R Patsch; W Wolfgang Fleischhacker
Journal:  J Clin Psychiatry       Date:  2003-12       Impact factor: 4.384

10.  Neonatal episodic hypoglycemia: a finding of valproic acid withdrawal.

Authors:  Dilek Çoban; Selim Kurtoğlu; Mustafa Ali Akın; Mustafa Akçakuş; Tamer Güneş
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-05-09
View more
  3 in total

1.  Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report.

Authors:  Petru Ifteni; Marius A Moga; Victoria Burtea; Christoph U Correll
Journal:  Ther Clin Risk Manag       Date:  2014-10-23       Impact factor: 2.423

Review 2.  Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis.

Authors:  Eline M P Poels; Lisanne Schrijver; Astrid M Kamperman; Manon H J Hillegers; Witte J G Hoogendijk; Steven A Kushner; Sabine J Roza
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-06-11       Impact factor: 4.785

Review 3.  Dilemma of treating schizophrenia during pregnancy: a Case series and a review of literature.

Authors:  Andreea Teodorescu; Petru Ifteni; Marius Alexandru Moga; Victoria Burtea; Nicusor Bigiu
Journal:  BMC Psychiatry       Date:  2017-08-29       Impact factor: 3.630
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.